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Abstract
Current infection therapies often require oral and topical drug administration. Over
the years, several studies have proven the lack of efficiency that characterizes these treat-
ments.
This work is focused on the development of an innovative biocompatible drug sup-
port, obtained by electrospinning using a polymer (Cellulose Acetate) with a drug model
(Rhodamine B), resulting on a nanofiber mat with the drug encapsulated. The encapsu-
lation was tested in both conventional and coaxial setups. The optimized membranes
were also functionalized with a conductive polymer (polypyrrole) to test electrical drug
delivery activation. Drug release profiles performed with passive (diffusion) and active
stimulation (electrical stimulus) were analyzed and compared.
The results obtained allowed to conclude that both types of membranes (convention-
ally or coaxially produced) were uniformly polymerized 45 minutes after the beginning
of the polymerization process. Moreover, positive stimulus polarity proved to induce a
higher response in terms of drug release. Additionally, different studies were also per-
formed with the aim of obtaining a better control over the released amount and release
instants, being therefore studied the sensibility of the membranes to a switchable-like
profile. As a result, it could be concluded that the higher the applied voltage, the closer
the obtained release profile was from an “on-off” pattern.
Keywords: electrospinning, coaxial electrospinning, drug delivery system, cellulose ac-
etate, rhodamine b, polypyrrole
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Resumo
As terapias de infeção atuais requerem geralmente administração oral e tópica de
fármacos. Ao longo dos anos, vários estudos comprovaram a falta de eficácia que ca-
racteriza estes tratamentos.
Assim, este trabalho tem como foco o desenvolvimento de um substrato biocom-
patível inovador, obtido por eletrofiação de um polímero (acetato de celulose) com um
modelo de fármaco (Rodamina B), resultando numa matriz de nanofibras com o fármaco
encapsulado. Ambas as configurações, convencional e coaxial, foram estudadas e otimiza-
das, e as membranas resultantes foram posteriormente funcionalizadas com um polímero
condutor (polipirrol). A cinética de libertação do fármaco foi analisada e os métodos de
administração passiva (difusão) e ativa (estímulo elétrico) foram realizados e comparados.
Os resultados obtidos permitiram concluir que ambos os tipos de membranas (pro-
duzidas por via convencional e coaxial) foram uniformemente polimerizadas 45 minutos
após o início do processo de polimerização. Além disso, a polaridade positiva do estímulo
induziu uma maior resposta em termos de libertação do medicamento. Adicionalmente,
diferentes estudos foram também realizados com o objetivo de obter um melhor controlo
sobre a quantidade libertada, bem como sobre os instantes de libertação, sendo, por isso,
estudada a sensibilidade das membranas a um perfil do tipo comutável. Como resultado,
concluiu-se que, quanto maior a tensão aplicada, mais próximo de um padrão "on-off"o
perfil de libertação obtido fica.
Palavras-chave: eletrofiação, eletrofiação coaxial, sistema de libertação de fármaco, ace-
tato de celulose, rodamina b, polipirrol
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Introduction
1.1 Motivation
The management of chronic wounds has emerged as a major health care challenge
during the 21st century, consuming significant portions of healthcare budgets, in terms
of the number of people affected and the expenses derived from their prevention and
treatment [1]. Chronic wounds, where full regeneration of the damaged tissue does not
complete in three months [2], such as diabetic foot ulcers, leg ulcers, or pressure sores
have a significant negative impact on the quality of life of affected individuals. Smart
systems that can monitor the wound environment without the need to visit so often
the medical facilities are extremely beneficial and this was the onset for a new field of
research, focusing mainly on sensors and actuators fabricated on flexible substrates.
Current infection therapies often require oral and topical antibiotic administration.
However, this kind of methods need much larger dosage since a great part of the antibiotic
gets wasted even before getting to the target location. Therefore, systems capable of
delivering drugs via a more controlled way become more therapeutically efficient, induce
less toxicity and decrease the number of doses administered [3].
Moreover, drug delivery systems are of particular importance as the ineffective vascu-
lature in the wound bed can prevent effective delivery of drug to the healing tissue when
the drug is administered systemically. In addition, the side effects of some drugs, the
low half-life of biological factors, and the dynamicity of the wound environment require
complex drug delivery systems that can deliver the active factors in proper dosage to the
appropriate location [4].
In drug delivery systems, the encapsulated antibiotic can be released through different
mechanisms which can be classified as active and passive delivery. In active delivery, the
release is triggered in response to an environmental stimulus (pH, temperature, enzymes,
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chemical reactions, redox reactions, etc.) or external stimuli (magnetic field, electric field,
light, ultrasound, etc.) [4]. In contrast, passive delivery relies on the diffusion of the drug
through the carrier matrix to reach the surrounding medium [5]. In this work, both kinds
of mechanisms will be studied, being active delivery induced by an electrical stimulus
and passive delivery studied for several conditions. An ideal application of an electrical
stimulus would be one which allowed an overall control over the release method. Such
control implies releasing the drug only if the stimulus had been applied and existing a
direct relation between the stimulus duration/strength and the amount of drug release.
This would give rise to an "on-off"release-like profile, in terms of the percentage of drug
release over time. Compared to other types of drug release profiles, the one mentioned
above would not only avoid the drug release burst, an excessive amount of drug that
is released as soon as the membrane is immersed in solution, dangerously associated
with high levels of toxicity, but also to an actuation on the wound area only at certain
pre-defined moments, improving the treatment’s efficacy.
Due to the limited regenerative capacity that characterizes the majority of the human
tissues and with the aim of avoiding the injury and subsequent degeneration derived from
such limitation, concepts like regenerative engineering emerged. Substrates capable of
controlling drug release rate and regenerating injured tissues have been a main topic in
research and development in this area. Among these, electrospun nanofibers offer unique
features compared to other types of substrates, namely a large surface area-to-volume
ratio, high porosity, uniformity in fiber size, flexibility and the ease of functionalization
with several bioactive molecules [6]. Moreover, these devices are capable of embedding
and deliver numerous drugs in a sustained and predictable way [7].
In this context, the work hereby presented aims to develop an innovative combination
of a carrier-drug system, obtained via electrospinning technique, followed by its function-
alization and finally the study of controlled drug release. By exploring new approaches
to the topic of drug delivery using an innovative carrier-drug combination, the conclu-
sions withdrawn from this work may help not only to contribute to a more economically
sustainable solution of studying and developing these types of systems, but also to better
understand how they work and how to optimize their efficiency.
1.2 State of the Art
The current work can be divided in three main tasks: membranes production, mem-
branes functionalization and controlled drug release. Thereby, the following literature
review will also be in accordance with these topics, being given detailed information
about previous work performed in each of those three areas.
With respect to the nanofibers production, for both types of electrospinning setups
(conventional and coaxial), the same carrier-drug system was used. As far as the author
is concerned, it is the first time that this system is being studied, either in the aim of a
drug release system, or in any other application. Therefore, this review will cover several
2
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works within each topic, with a focus on the studies that worked with the same materials
as the current one, however in a separate way. As the carrier, a Cellulose Acetate (CA)
solution was chosen and, as the model drug, Rhodamine B was employed. Looking for-
ward to obtain optimal work conditions, the preparation of such solutions needed to be
carefully studied to optimize the work from such an early phase. Thereby, Tungprapa et
al. 2007 [8] on their studies about the effect of solvent system on the morphology and
fiber diameter concluded that one of the most versatile and consistent solvent system to
perform CA electrospinning was the acetone:N,N-dimethylacetamide (DMAc) in the pro-
portion of 2:1. Moreover, several attempts of blending CA with different drugs, namely
Naproxen, Indomethacin, Ibuprofen, Sulindac and Curcumin, were performed using the
same solvents proportion mentioned above [8], [9]. Supported by these evidences, this
binary system was the solvent combination used in this work to prepare CA solutions.
Despite being introduced a few years before, only in 1934 had electrospinning been
accepted as a nanofiber fabrication technique, with the work developed by Formhals
[10],[11].
Since then, several authors published many works where they executed this technique
under various conditions, in order to understand what parameters influenced the forma-
tion of a continuous and defect-free membrane. Enumerating only a few as an example,
Taylor et al. 1969 [12] studied the effect of changes in the applied voltage; Zong and
coworkers 2002 [13], in turn, found out that a minimum flow-rate of the polymer during
the process is needed to replace the solution that is lost when the nanofiber jet is ejected;
in a study conducted by Baumgarten 1971 [14], the relationship between distance to
collector and size and morphology of the fibers was studied.
If the drug and the polymer are soluble in the same solvent, the drug can be dissolved
directly into the polymer solution. Electrospinning of this kind of solutions results in
the embedding of the drug in the nanofiber scaffold. However, in terms of drug release
profile, an initial burst release is going to be expected, due to the drug distribution on
the surface of the nanofibers, large nanofiber surface areas and the amorphous status of
the drugs inside the nanofibers [15].
The burst release mentioned above continues to be one of the major weaknesses of
drug release systems and is potentially harmful to patients in clinical applications. One
possible solution to attenuate this effect would be to change nanofibers configuration
in order to get a better drug encapsulation. With this purpose, in 2003, Sun et al. [16]
introduced the concept of coaxial electrospinning. In their work, they obtained core-shell
nanofibers made of two identical polymers (poly(ethylene oxide) and, in a similar way,
they obtained a compound made of two different polymers (poly(ethylene oxide and
poly(dodecylthiophene)). For the first time, a distinguishable separation between a shell
and a core was obtained, as shown in Figure 1.1.
Such discovery brought numerous advantages to the field of drug release systems,
among which a better encapsulation of the core material is one that motivated the use of
co-electrospinning in this work, but it also requires some specific characteristics between
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Figure 1.1: TEM of a compound nanofiber (adapted from [16]).
the materials involved. In terms of solution viscosities, co-electrospinning works better
when the shell solution has a good spinnability and sufficient viscosity to overcome the
interfacial tension between core and shell solutions [17].
Kao et al. 2015 [18] confirmed that, similar to the conventional electrospinning setup,
the higher the concentration of the solutions, the higher the fibers diameter.
When choosing solution solvents, this process has to be made carefully so that a stable
compound jet can be formed, with neither of them resulting in the precipitation of the
other. Despite it has already been proven that two miscible solution can be electrospun
[16], its tendency to get mixed up in the electrospinning process clearly overcomes the
low probability of it to work correctly. Thereby, the ideal co-electrospinning is made of
two immiscible solutions, since they ensure phase separation during the spinning process,
as studied by Kurban et al. 2010 [19].
Moghe and Gupta 2008 [20] stated that for a given pair of polymer solutions, there is
a small range of voltage values which can be applied so that a stable compound Taylor
cone can be formed.
Identical to conventional electrospinning, in the coaxial process the flow rates chosen
for both the core and the shell solution also have a crucial impact on the resulting fibers
[17]. Interesting studies by Nguyen et al. 2012 [21] led to the conclusion that lower feed
ratios resulted in higher stability of the core sheath structures, but at the same time, the
inherent high viscous stress at these rate values resulted in the break down into several
individual segments of the core material. According to Xia et al. 2014 [22], optimum flow
rates combination is also related with the thickness of the resulting fibers.
Therefore, the first part of the work hereby presented will explore and combine these
and other concepts that were mentioned above and apply it to the not yet explored com-
bination of cellulose acetate-Rhodamine B system. A search for the optimal conditions to
obtain nanofibers of the carrier-drug system chosen will be explained in the subsequent
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chapters.
Once optimized and obtained the nanofibers mat, and since cellulose acetate fibers
are characterized by a weak electrical conductivity [23], functionalization of these mem-
branes with a conductive polymer is needed in order to turn them stimuli-responsive.
Thereby, due to its high conductivity, biocompatibility and low-cost process [24], [25],
Polypyrrole (PPy) was the polymer chosen to functionalize the membranes presented in
this work.
Jin et al. 2016 [26] have successfully developed a conductive PPy-PLLA (poly-L-lactic
acid) composite film, through casting film, to study an electrically controlled delivery
system of the protein Bovine Serum Albumin (BSA). The electrical conductivity of PPy-
PLLA composite film was 3.33±2.0×10-3 S/cm.
More recently, Baptista and fellow research team [27] developed flexible, lightweight,
non-toxic and conductive cellulose based electrospun fibers and functionalized them with
PPy, by in situ polymerization. The approach done in the work here presented follows the
same procedure as this one. In the mentioned study, a careful and detailed analysis was
performed in terms of monomer concentrations, polymerization times and concentration
of the oxidizing agent. Conductivity values increased remarkably up to 10-2 S/cm.
The first time electrospun fiber mats were studied as drug delivery vehicles, Kenawy
et al. 2002 [28] used tetracycline hydrochloride as a model drug and the fibers were elec-
trospun from chloroform solutions. Their work first introduced the concept of analyzing
the drug release profile via UV-Vis spectroscopy.
That work was the onset for a major field of research and development nowadays. Up
till now, many studies were driven by the aim of obtaining better and more efficient drug
release systems.
Nista and coworkers [29] 2013 produced nanofiber membranes of cellulose acetate
and tried out four different types of solvent combinations. Among the four detailed
in their work, the one that most matters to reference here is the DMAc/acetone/water
combination. The reason is related to the fact that in the presented work, the model drug
will be dissolved in water and further electrospinned using the coaxial setup, where it will
be in contact with cellulose acetate. The intended interaction between water and cellulose
acetate is going to be tried out in order to get an optimal encapsulation of Rhodamine
B, creating a barrier effect between the shell and the core of the nanofibers. Due to the
incompatibility between water and cellulose acetate, understanding the proportion that
must exist between both materials so that one does not lead to the precipitation of the
other is important. In their work, Nista and her team used 63:32:5 ratio between the three
solvents mentioned above, respectively.
In the study taken by Liao et al. 2009 [30], the hypothesis of impregnating a compos-
ite nanofiber mat (resultant of an emulsion which included poly (lactic-co-glycolic acid)
(PLGA)) with Rhodamine B particles (used as a model compound to simulate drugs) was
tested out, being studied its encapsulation/release performance. They concluded that the
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composite nanofibers mat electrospun from the emulsion exhibited the desired control-
lable release performance. This study proved as a good example of how Rhodamine B
can be used to model a drug in this kind of simulations.
González and Frey 2017 [31] worked on the development of stimuli-responsive nanofibers,
in their case sensitive to temperature. Nanofibers were obtained from the conventional
electrospinning of an innovative combination between Poly(vinyl caprolactam) (PVCL)
and hydroxymethyl acrylamide (NMA), resulting in the formation of chemical hydrogel
nanofibers. To study the sensitivity of nanofibers, Rhodamine B was incorporated by dis-
solving the dye directly in the initial electrospinning solution. As a result, they managed
to analyze and built the release kinetics in function of an external stimulus.
The review, made so far, over the studies performed in the topic of drug release,
covered just the conventional electrospinning technique. Looking to what has been done
by taking advantage of the full potential that coaxial setup has to offer, several interesting
works can also be found.
Entering in a dimension that overgoes the expectations of the present work, Su et
al. 2012 [32] presented the scientific community a whole new set of capabilities that
drug delivery systems have to offer. The purpose of their work was to develop a type of
tissue-engineering scaffold with the capability of encapsulation and controlled release
of dual drugs (Rhodamine B and Bovine Serum Albumin). Several combinations were
tried, changing the location of both drugs (between the core and shell). Poly(L-lactide-
co-caprolactone) (PLLACL) and 1,1,1,3,3,3-Hexafluoro-2-propanol (HFP) were the other
fiber constituents, apart from the drugs. The main conclusions were that, from drug
release profiles, it could be stated these are dependent on the location the drug or protein
are put into. This can have significant implications depending on the type of application
that will be given to these fibers, whether tissue regeneration, combined therapies or
cancer treatments.
According to Giuseppi-Elie, in his review work [33], electro-stimulated drug release
devices are devices that produce a programmed drug release profile influenced by the
application of voltage or even current. To understand if the membranes produced and
functionalized in this work are really sensitive to the electric stimulus, one of the objec-
tives proposed is to study whether the carrier-drug system used is capable of showing
a switch ON/OFF capability. This means that, by applying electrical stimulations, drug
release should increase faster, decreasing its release speed during the periods of no ap-
plication. The release profile of such drug delivery system would show a step-like curve
throughout the graph. Studies developed by Pérez-Martinez et al. 2016 [34] and Li et
al. 2015 [35], by using Rhodamine B as a model drug compound, succeed on their aim
of getting this switch behavior. An example of an ON/OFF release profile is depicted in
Figure 1.2.
Table 1.1 summarizes the most relevant research work presented above in each of the
three parts this work is divided in.
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Figure 1.2: Release profile of Rhodamine B under an on-off voltage change (adapted from
[35]).
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Materials and Methods
In the following chapter, a detailed explanation of the materials and meth-
ods employed during the work will be given. Thereby, a look over the pro-
duction of membranes process, its corresponding functionalization methods
and several characterization techniques will be taken. Details about the per-
formance of controlled release tests will also be explained.
2.1 Membranes Production
In this first section of the work here presented, the main goal was to use conventional and
coaxial electrospinning parameters to produce polymer-based fibers with a model drug
encapsulated. In both types of setups, cellulose acetate was used as the carrier polymer
and Rhodamine B was chosen to model a drug.
• Materials
– Cellulose Acetate
Due to its numerous applications, polymer fibers are the subject of several studies
[36]. Although the industrial branch is the one that most benefits from such applications,
an emerging interest in the study of these polymers for health applications has been
noted. Particularly in the topics covered in this project, membrane production and drug-
controlled release, the characteristics that are most sought in the polymers studied are
their biocompatibility, cost-effectiveness relationship, toxicity and solubility.
In this context, one of the polymers that best matches the characteristics imposed is
cellulose acetate. Being one of the most important organic esters derived from cellulose,
Earth’s major biopolymer, cellulose acetate results from the replacement of hydroxyl
groups of each glucose unit by acetyl groups [37].
9
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The mean number of hydroxyl groups replaced by acetyl groups express the degree
of substitution [38]. This, in turn, is directly related to the crystallinity of the polymer,
its biodegradability and solubility in different solvents, among other properties. Figure
2.1 shows the cellulose acetate structure. Given its advantageous features, namely its low
cost, high level of biocompatibility and non-toxicity [39], [40], cellulose acetate was the
polymer chosen to form the nanofibers studied in this work.
Figure 2.1: Cellulose Acetate Structure. R = CH3CO or H (adapted from [41]).
– Rhodamine B (RhB)
Rhodamine B (Figure 2.2) is a synthetic organic dye, widely used as a fluorescent
tracer in many applications due to its high water solubility, low cost and its corresponding
emission spectra, which presents a distinguishable peak of absorption in the visible region
[42]. These range of characteristics allows rhodamine B to be used, as reported several
times, as a model drug with the aim of studying controlled-drug release systems.
Figure 2.2: Rhodamine B Structure (adapted from [43]).
Its fluorescent magenta characteristic eases the process of absorbance readings, which
in turn allows for a convenient representation of the amount released with respect to time.
As previously stated in the Literature Review section, RhB has already been incorporated
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in many studies using different electrospinning setups and in some cases followed by
corresponding release study [31], [32], [35]. This helps to prove that RhB is not only a
more economically-affordable solution to model a specific type of drug (one with similar
chemical and molecular properties), but also to accurately mimic that kind of medication.
– Solutions
In terms of solutions preparation, in the case of conventional electrospinning, one
solution was used, which consisted on a 8% (w/w) CA solution (Mn ∼ 50000, 20-40%
acetyl groups, Sigma-Aldrich) in 2:1 acetone:DMAc solvent mixture, to which were added
4.3 x 10-3 grams of Rhodamine B (≥ 95% (HPLC), Sigma-Aldrich), corresponding to the
same mass weighted in the preparation of Rhodamine B solution used in coaxial setup.
For coaxial electrospinning process, two solutions were prepared. The shell solution
was the same CA solution with the same solvent mixture ratio detailed above, as for
the core solution a 0.6 mM Rhodamine B was used. Apart from the detailed solutions
above, few others were tried throughout the practical work, namely druing the coaxial
electrospinning process. With the same solvent ratio mentioned before, a 12% (w/w) and
a 18% (w/w) CA solutions were produced and tried out as shell solutions. For the core
solution and in a similar preparation as the 0.6 mM solution, a 1.5 mM solution in the
same water volume (20 mL) was developed and combined with different CA solutions.
• Methods
– Electrospinning: conventional and coaxial setups
Electrospinning is a widely used technology that utilizes the electric force to drive the
spinning process and to produce polymer fibers. Diameters of the fibers produced can
range from 2 nm to several micrometers, which differentiate electrospinning from other
conventional techniques to produce fibers. The small size of each individual fiber leads,
in turn, to large specific surface areas. This combined with the characteristic high porosity
of the obtained fiber mat, with inter-connected porous network, allows for a better and
easier encapsulation and immobilization of drug molecules. Additionally, the ability to
modify surface properties of the obtained membranes, by means of functionalization
processes, render electrospinning one of the most versatile fiber-fabrication techniques
[30], [44], [45].
In a conventional electrospinning setup, a polymer solution is hosted in a syringe
with a needle, to which a high voltage power supply is linked to, as depicted in Figure
2.3. When the voltage is applied, the particles within the solution are charged creating
a repulsive force. At this point, the liquid drop that is on the tip of the needle is under
several forces, namely the repulsive forces mentioned above, the attractive forces from the
oppositely charged collector and the surface tension inherent to the polymer solution. As
the electric field strength increases, electrostatic forces will also increase, until it reaches
11
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Figure 2.3: Conventional Electrospinning
Setup (adapted from [46]). Figure 2.4: Conventional setup used in this
work.
a certain point where these forces equal the surface tension of the solution, the liquid
drop becomes a cone, most known as the Taylor cone. At a critical voltage, the repulsive
forces overcome the surface tension, which results in the eruption of a jet from the tip of
the needle directly to the grounded collector. During the time the jet takes to reach the
collector, if the distance between the apparatus and the collector is enough, the solvents
that are present in the solution evaporate, resulting in the random deposition of fibers
throughout the collector [23], [45].
In order to optimize the functionality and efficiency of membranes regarding the con-
trolled drug delivery purpose, an alternative way of producing fiber mats was explored
during this work. Thereby, coaxial electrospinning parameters were studied and ana-
lyzed, so that an optimal encapsulation of the model drug used could be achieved. This
method is used to prepare double-layered nanofibers with a core-shell structure. In terms
of functioning, the theoretical concepts behind coaxial electrospinning are the same as
for the conventional setup, except that in the coaxial setup two separate solutions (core
and shell) flow through two different but coaxial needles. The setup used is shown in
Figure 2.5B.
To avoid bead-like defects in nanofibers production, several parameters must be con-
sidered. In terms of process parameters, the applied voltage is of great importance, as it is
strongly related with the resultant fiber diameter and the formation of beads. It directly
depends on the polymer-solvent system used. The flow rate chosen has a direct impact
on the diameter, fiber mat’s porosity as well as on fiber geometry. As mentioned before,
the distance between the capillary tip and the collector also affects fibers diameter in an
inverse relationship. From process to system parameters, the latter ones are related with
polymer concentration, solvent volatility and solution conductivity. They are directly
related to the viscosity and surface tension of the solution, the formation ability of the
fibers and corresponding surface topographies and fiber size, respectively. In the tables
below, a more detailed information about the optimal conditions found to perform each
type of electrospinning process is given.
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Figure 2.5: Coaxial electrospinning needles detail (A) (adapted from [47]) and coaxial
setup used in this work (B).
Table 2.1: Optimal conventional electrospinning parameters obtained.
Needle Gauge 21
Ground Collector Distance [cm] 15
Applied Voltage [kV] 20
Deposition Time [hours] 4
Relative Humidity [%] 30-45
Temperature [ºC] 20-23
Table 2.2: Optimal coaxial electrospinning parameters obtained.
Core Shell
Solution RhB:H2O CA:acetone:DMAc
Syringe Volume [ml] 2 5
Flow rate [ml/h] 0.06 0.4
Needle Gauge 15 11
Grounded Collector Distance [cm] 12
Applied Voltage [kV] 19.5
Deposition Time [hours] 2h30
Relative Humidity [%] 35-40
Temperature [ºC] 22-24
To produce the fibers, in both configuration types, a syringe pump (KDS100) was used
to control the flow of the solution through the needle, that in the case of conventional
setup (ITEC, Iberian Technical, Lda., 21G) was at the constant rate of 0.2 mL/h for a
syringe (B.Braun) of 1ml and, for the coaxial setup (Double Layer Coaxial Needles, Linari
Engineering) was at a core/shell rate of 0.06/0.4 mL/h, for syringes of 2/5 ml, respectively.
While the syringe pumps were responsible for squeezing out the polymer solutions at
a controllable speed through the needles, a high voltage was being applied (using a
Glassman High Voltage Power Supply) between the needle and a grounded static collector,
13
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coated with an aluminum foil.
2.2 Membranes Functionalization
In the following section, a look over the polymer used to functionalize the membranes
obtained via electrospinning will be given. It mentions the advantages of using such
polymer and the procedure that was adopted throughout the experimental work to carry
out the polymerization.
• Materials
– Polypyrrole (PPy)
Polypyrrole is one of a series of heterocyclic polymers which has attracted much atten-
tion due to its characteristic electric and electronic properties [48] . Its high conductivity,
biocompatibility and low-cost process turn PPy into a very interesting polymer to func-
tionalize the membranes mentioned in the previous section. Furthermore, its usage in
several previous controllable drug delivery studies contributed to choose PPy as the con-
ductive polymer to be used in the current work.
• Methods
– In situ oxidation of Pyrrole in aqueous solution
Dried membranes obtained whether by conventional or coaxial electrospinning with
approximately 3 cm x 2 cm of dimensions were coated with PPy through in situ oxidative
polymerization. The functionalization process consisted in the use of Pyrrole (C4H5N,
Sigma-Aldrich, Mw = 67.09 g/mol, 98% assay) as the monomer and Iron (III) chloride
hexahydrate (FeCl3.6H2O, Sigma-Aldrich, Mw = 270.30, 98% assay) as an oxidizing agent,
in a 2:1 ratio. This ratio resulted from the optimized studies performed by Baptista and
coworkers in their work about organic batteries made upon cellulose-based electrospun
fibers. [27]
To initiate the functionalization, a 20 ml aqueous solution of 0.05 M of pyrrole was
prepared and was left stirring for 10 minutes. Then, the dried membranes with dimen-
sions mentioned above were added and stirred for another 10 minutes, so that they could
be soaked with the monomer. The polymerization step started by adding 0.134 g of the
monomer to the solution and within a few minutes the membranes started to get black,
confirming the formation of PPy. The solution was stirred for 45 minutes, in order to
get a fully polymerized membrane. The final step consisted in a thoroughly wash of the
membranes, with distilled water and ethanol, so that all the by-products and residues
resultant from the reactions occurred could be extracted. To complete the process, the
membranes were left drying at room temperature.
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2.3 Characterization Methods
• Morphological Characterization
Morphological characterization was important in the present work not only to char-
acterize, logically, the morphology of the fibers obtained, but also to measure their di-
ameters and compare the different types of membranes obtained throughout the work.
These might include whether the fiber mat contained bead-like defects, if the polymeriza-
tion occurred uniformly through all the membrane, if the release tests affected the fibers
morphology, among others.
– Optical Microscopy
The optical microscope is the traditional technique of microscopy, allowing the study
of certain samples up to the micro and even sub micrometer scale. Comparing to other
microscopy techniques, this one takes advantage on the much easier handling and sam-
ples preparation that is needed to perform the task, but having the scale limitation that
other methods do not have. In the work presented, despite the main topic covered being
nanofibers, the use of the optical microscope, model Leica DMi8, was justified by the high
fluorescence levels of Rhodamine B. By exploring the filters present in the microscope,
one in specific had excitation and emission values near the same range as the model
drug itself (excitation: 554 nm; emission: 580 nm), as shown in Figure 2.6. Given the
suitability of the RHOD filter, its use enabled the verification of whether the Rhodamine
was present in the membrane. Moreover, a more general observation over the fibers mor-
phology, the presence of bead-like defects, among other characteristics, could be done,
clearly without the same magnification as the ones obtained by the Scanning Electron
Microscopy technique, for example.
Figure 2.6: Similarity between values of RhB and the Leica RHOD filter.
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– Scanning Electron Microscopy (SEM)
SEM is a technique that allows the collection of high-resolution, high-magnification
images of the samples analyzed. In a general and more brief way of looking at SEM’s
functioning process, it uses a narrow electron beam to scan a certain area of the sample.
From the interaction between the beam and the atoms of the sample involved, it results
the emission of low-energy secondary electrons (1-20 eV). The intensity of this emission
is, thereby, a function of the atomic composition of the sample and the geometry of the
sample’s piece that is being observed. Due to the narrowness of the excitation beam,
the resultant beam has a high depth-of-field that, otherwise, could not be obtained by a
common optical microscope.
In the work hereby presented, samples were prepared by cutting some pieces of differ-
ent types of membranes, varying either in the type of production method (conventional
or coaxial electrospinning) and in several conditions related to controlled release tests
(namely, before stimuli application and after stimuli application for both types of po-
larity). Then, they were placed on a metallic sample support by means of a conductive
carbon strip. The model used to perform the technique was the JEOL 7001 and the
resulting images were analyzed using ImageJ® image processing software.
Additionally, a histogram analysis is made relating the different fiber diameters reg-
istered for each sample with the relative frequency with which they exist in the piece
of sample analyzed. The diameter measure of the fibers was performed with ImageJ®
software, considering 50 different measurements for each sample (10 measurements for
each of the most superficial 5 fibers).
• Electrical Characterization
– Electrical Conductivity
The membranes produced right after electrospinning process, because of their com-
position (mainly cellulose acetate and a much less amount of drug), are considered non-
conductive. That is the reason why their functionalization is required, in order to turn
them into electro-stimuli responsive membranes, so that the controlled delivery tests can
be performed.
Electrical characterization takes part in this work right after the PPy polymerization
step, to measure the conductivities of the membranes before subjecting them to an electric
stimulus. That same conductivity values will then be compared to the ones obtained after
the controlled release tests have been performed, from where conclusions can be taken
on the effects that the stimulus had on the membrane’s conductivity.
The conductivities measurement process is performed with resource to a Picoamme-
ter/ Voltage source (Keithley Series 6400 Picoammeters) and a computerized microprobe
(Alessi REL-450) with two positioners. The setup used is depicted in Figure 2.7.
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Figure 2.7: Conductivity measurements setup. Upper left figure: overall setup; Upper
right and lower figures: illustration of the transversal measurement setup, with a detail
over the positioning of the membrane in the microscope slides and its pressing between
two conductive carbon foils.
As a result of each measurement, either in the planar or transverse planes, a Current-
Voltage Characteristic Curve (I-V Curve) is obtained. This type of curves shows the re-
lationship between the current flowing through an electronic device and the applied
voltage across its terminals. According to Ohm’s law,
V = RI (2.1)
Which states that the slope of the straight line that represents the current (I) against
the potential difference (V) is equal to 1/R (in the case of an ideal resistor). Thereby,
by obtaining the I-V Curves and sorting out the resistance (R), the functionalized mem-
brane’s conductivity, σ in Siemens per centimeter (S/cm), can be obtained by applying
the following equation:
σ =
l
AR
(2.2)
Where l represents the length of the piece of material, A represents the cross-sectional
area where the current has passed-through, and R represents the resistance.
Conductivity was measured and compared in both planes (transverse and planar),
being the transverse plane measured by pressing a membrane of 2,5 x 1 cm between two
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microscope slides, coated with conductive foils of carbon (setup is depicted in 2.7). As
for the planar measure, membranes were cut and immobilized on microscope slides with
conductive glue, like represented in Figure 2.8. In the case of the transverse measurement,
the cross-sectional area corresponded to the area of the slide where the membrane was
inserted into; as for the planar setup, this value was obtained by multiplying the distance
between electrodes (1 cm) by the corresponding membrane thickness. Functionalized
membranes resulting from both conventional and coaxial electrospinning setups were
analyzed.
Figure 2.8: Planar conductivities samples preparation. Three distinct membranes are
cut into similar size pieces and glued against a microscope slide with a conductive glue.
Measurements are performed between the two edges of the membrane, i.e, between the
two glue spots.
2.4 Controlled Drug Delivery Tests
After membranes production and corresponding functionalization, the simulation and
analysis of the drug release behavior was performed. In a general approach to this topic,
the membranes are first inserted into a recipient with water, being then subjected to
a potential difference, between the membrane and an electrode, corresponding to the
electrical stimulus. Applying the stimulus during a certain period, repeating it several
times in a determined sequence, gives rise to a controlled drug release study. After
each stimulus, the absorbance of the medium is measured, using the UV-Vis Absorbance
Spectroscopy technique. Correlating the values obtained with the resultant equation that
emerges from a previous performed calibration curve, an approximation of the amount
of drug that was released after each stimulus can be done. Once known the amount of
drug released, different types of data processing can be made, such as a cumulative drug
release graph in function of time.
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– UV-Visible Spectroscopy
UV-visible spectrometers can be used to measure the absorbance of either ultra violet
or visible light by a sample. In the work presented, the range analyzed went through both
types of radiation, from 190 nm to 900 nm.
Inside a spectrometer, a light source emits a beam of white light. This beam then
goes through a monochromator and is focused onto a diffraction grating that can split the
incoming light into its different component colours. The diffracted beam than goes by a
beam splitter, which splits the beam towards the two cells or cuvettes. One of them, the
reference cell, also called blank, contains the solvent in which the sample is dissolved;
the other one, the sample cell, contains the sample that is pretended to be analyzed.
The intensity of light passing through both the reference cell (I0) and the sample cell
(I) is measured by the detectors. If I is less than I0, it means that the light was absorbed
in the cuvette that contains the sample. The absorbance value (A) is related to these
intensities by the following equation:
A = log10
I0
I
(2.3)
During the experimental work, 3 ml of distilled water were used to correct the baseline
of the equipment (PG Instruments Ldt., T90+ UV/VIS Spectrometer). After each stimulus
application, the absorbance was measured and plotted for each wavelength, using UVWin
Spectrometer Software.
As mentioned above, in order to know the concentration of RhB released, a previous
calibration curve had to be done. This relationship is explained by the Beer-Lambert Law,
which states that the absorbance is proportional to the concentration of the substance in
solution, expressed in the form of the following equation:
A = cl (2.4)
Where:
A = absorbance
I = optical path length, i.e. dimension of the cell or cuvette (cm)
C = concentration of solution (mol dm-3)
 = molar extinction, constant for a particular substance at a particular wavelength
(dm3 mol-1 cm-1)
Thereby, if by plotting a range of absorbance values in function of known concentra-
tions, a linear relationship is obtained, as theoretically expected by the Beer-Lambert Law,
such graph can be used as a calibration curve.
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– Calibration Graph
An initial study of how absorbances of RhB in water vary with different drug concen-
trations is needed in order to understand and further analyze the results obtained in the
controlled release tests.
To obtain the calibration curve, solutions with varying concentrations were prepared.
From a stock solution of 0,6 mM of RhB in water, other concentration values were ob-
tained by diluting that high concentrated solution. The prepared solutions are listed
in Table 2.3 and their colour change pattern is shown in Figure 2.9. The different ab-
sorbances were measured, the plots were analyzed, and a calibration curve was done.
Table 2.3: Concentrated solutions used in the calibration curve
Rhodamine B in water calibration curve concentrations [mM]
0.001 0.002 0.003 0.005 0.006 0.008 0.010 0.015 0.020 0.025
Figure 2.9: Colour difference between different concentrated solutions. The red solution
corresponds to the stock solution.
– Diffusion Drug Tests
Since the model drug used, RhB, is water-soluble, it is important to analyze how much
of the drug is released by normal diffusion, only by being immersed in water. This study
is even more important if we consider that during the polymerization step, membranes
are totally immersed while being coated with PPy. Furthermore, to clearly identify how
much of RhB is released only due to the stimulus, an idea of how much rhodamine is
released just by immersing a functionalized membrane in water is mandatory.
To perform this task, a recipient is filled with 20 ml of distilled water and, for the case
of an uncoated membrane, this one is fully immersed in water, being the absorbances
measured in specific time intervals. The same procedure is taken for the case of PPy
coated membranes, with the difference that only the same portion of membrane that is
immersed into water in the controlled released tests is inserted in water during the assay.
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– Drug Controlled Release Tests
The setup used to perform the drug-controlled delivery tests is depicted in Figure
2.10. A recipient is filled with 20 ml of distilled water, where a functionalized membrane
is immersed with a silver electrode. To avoid unnecessary variations between measures,
it is important to keep the distance between the electrode and the membrane throughout
every test. The membrane is connected to the positive pole of a high voltage supplier
(Keithley 237 High Voltage Source Measure Unit) and the electrode is connected to the
negative pole. Each test is made up by several stimuli application times, with the same
polarity but with different values, for each type of membrane.
Figure 2.10: Controlled drug release setup. Part of the membrane is immersed and
connected to the positive pole of the voltage supplier and is placed in a constant distance
from a negatively charged silver electrode.
Every sample is immersed in a new medium for each new test. During a test and after
application of a stimulus, the apparatus (membrane and electrode) is removed from the
water, 3 ml of the medium are withdrawn and measured in UV-Vis Spectroscopy and then
returned to the same solution.
Both types of membranes (from conventional and coaxial electrospinning) were tested
through positive and negative stimulus (in the range of 1 V to 5 V, during 1 - 5 minutes),
being also studied the condition of 0 V, to understand whether it would impact the drug
release and if there was any difference comparing with the normal diffusion tests.
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Results and Discussion
In the chapter hereby presented, the results obtained throughout the ex-
perimental work will be shown and discussed. A detailed analysis over the
different techniques mentioned in the previous chapter will be done, starting
with the morphological characterization of the produced and functionalized
membranes. This section also presents in detail the results obtained for the
controlled drug delivery tests.
3.1 Production and morphological characterization of
electrospun membranes
From a technological point of view, conventional electrospinning can be considered to
be easier and faster, since it just needs a blend between the desired drug and the polymer
and a few parameter adjustments. However, as stated in previous chapters, this electro-
spinning method has several side effects, such as the homogeneous drug distribution in
the overall fiber and the consequent burst release effect, which might turn to be harmful
to the patient [15].
Given the unique advantages that coaxial electrospinning offers compared to the
conventional setup, mainly in terms of a better drug encapsulation and the significant
attenuation of the burst effect, the main goal of this work, right in its beginning, was to
explore and optimize nanofiber production via this latter method.
Therefore, and starting by pumping into the core a solution of 0.6 mM of Rhodamine
B in water, together with a 12% (w/w) CA solution, several attempts were tried, and none
worked. The process was unstable, and it was not verified any uniformity in the resultant
membranes. Several flow rate combinations were attempted and distance to collector was
altered too, as well as different values of the applied voltage (in a range between 15kV -
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20 kV). One possible reason to justify such difficulty in obtaining uniform membranes
could be the excessive amount of water that was being put into contact with CA. To
clarify this situation, a more concentrated solution of Rhodamine B (1.5 mM) was tried
instead of the 0.6 mM solution, in an effort to reduce the amount of water directly in
contact with cellulose acetate. Since the results did not changed substantially, instead of
dissolving Rhodamine B in water, the dye was dissolved in the same amount in ethanol.
The only condition that inhibited ethanol of being chosen as a preferential solvent was its
considerable miscibility with cellulose acetate. This miscibility would have the negative
effect of a weaker drug encapsulation capacity (compared with water), thus enabling
more drug to get released by diffusion. In the opposite logic, the immiscibility that
characterizes water-cellulose acetate relationship was the reason that led to use water as
the solvent in the process, looking forward to a better encapsulation of the model drug.
In Table 3.1, the combinations that were attempted throughout the work are listed.
Table 3.1: List of combinations attempted during the coaxial electrospinning process.
As it can be stated from Table 3.1, the only combination that was able to produce
a uniform and continuous membrane was the last one, with a lower cellulose acetate
concentration. As seen in images obtained via Optical Microscopy (Figure 3.1) and as it
would be expected, this mentioned combination does not allow a perfect and defect-less
membrane production, but it was the only option that enabled the coaxial process to be
used throughout the practical work. Since no other study using the same carrier-drug
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combination as the one used in this work was found in the literature, a more exhaustive
and exploratory work had to be done to find the desired conditions. The starting point to
do so were the conditions used in previous studies using the same drug model, namely
[32], [49], [50].
Parallel to this work, in order to get a comparison alternative for the coaxially elec-
trospun membranes, a conventional setup was used as well. Oppositely to the coaxial
process, in the conventional method only one solution is electrospun through the only
needle that exists. Therefore, in this case, Rhodamine B was incorporated in the cellulose
acetate solution preparation. The same concentration (0.6 mM) that was diluted in wa-
ter for the coaxial setup, was diluted in the acetone:DMAc solvent mixture used in the
production of CA. The first conditions tried were the same as those used to electrospin
a typical solution of cellulose acetate [23]. Those conditions were the optimal result of
a complete exploratory work, thereby reducing the time consumed in this work to do
so, like it was done for the coaxial electrospinning. Once again, 8% (w/w) CA was used,
which had the advantage of enabling a continuous and uniform membrane to be obtained,
but at the same time, its low viscosity might has led to the presence of some defects in
the resulting fibers (Figure 3.1).
Despite the orders of magnification are not enough to reach the nanofiber level, Op-
tical Microscopy technique, as mentioned in the Materials and Methods chapter, was
a technique employed in this work to verify whether the membranes that were being
produced contained Rhodamine B. This was possible due to its high fluorescence level
(excitation/emission wavelengths - 554 nm/580 nm) and by the similarity between ab-
sorption/excitation values of RhB and the RHOD filter of the microscope (Optical Mi-
croscopy sub-section, previous chapter). An example of the type of images obtained is
depicted in Figure 3.1. As expected, the strong fluorescence property of RhB, denoted by
the higher brightness in the images, is an indicator that the fibers being produced contain
the model drug.
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Figure 3.1: Optical Microscopy images (Bright Field filter - left; RHOD filter - right). A
and B correspond to fibers obtained via coaxial setup and C and D to the ones produced
via the conventional setup.
Figures A and B depict an individualized fiber produced using a coaxial electrospin-
ning process showing a uniform brightness. On the other hand, Figures C and D, present
several fibers produced using a conventional electrospinning setup. A detailed analysis
over these and other images with different magnifications leads to the observation of
bright dots spread all over the membrane. The presence of these bright spots can be
explained by a non-uniform dispersion of Rhodamine within the fibers or due to beads
formation during the electrospinning process - either in conventional or coaxial setup –
probably caused by the low viscosity of the solution.
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Besides some difficulties in obtaining a stable and reproducible ES process, the se-
lected ES parameters for both setups allowed the production of fibers with encapsulated
RhB.
Later, SEM analysis was carried out for a detailed morphological characterization of
the produced electrospun membranes. Figure 3.2 presents the SEM images of CA fibers
and CA + RhB fibers produced via conventional and coaxial ES setup.
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Figure 3.2: SEM images and corresponding histogram for fiber diameter analysis. Number
1 of each set corresponds to a magnification of x5000 and number 2 to a magnification
of x30000. First set of pictures (A) corresponds to CA fibers (8% wt). Set B to CA+RhB
produced by the conventional electrospinning setup. Set C to CA+RhB obtained via
coaxial electrospinning.
In general, the SEM images presented in Figure 3.2 show randomly orientated elec-
trospun fibers with a high fiber diameter distribution. Cellulose acetate electrospun
fibers (Figure 3.2A) clearly present a bead-like morphology due to the low viscosity of
the polymeric solution. After RhB encapsulation within fibers using conventional ES
setup (Figure 3.2B), it is clear that fiber morphology does not significantly change. This
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bead-like morphology may explain the presence of the bright spots previously mentioned.
Using the coaxial setup to encapsulate RhB (Figure 3.2C), the electrospun fibers
showed a higher average diameter and a rough surface. The larger diameters are due
to the larger gauge of the outer needle used for coaxial setup when compared with the
conventional one - as previously stated in Tables 2.1 and 2.2 of the Materials and Methods
chapter. The surface roughness can be probably explained by the interaction of cellulose
acetate molecules in the shell with the water molecules embedded in the core (containing
RhB).
Interestingly, membranes produced by both types of electrospinning setup showed
similar values in terms of membrane thickness. In the case of the conventional setup,
resultant membranes had an average thickness of 0.051 ± 0.013 mm, and the ones elec-
trospun via the coaxial setup resulted in an average thickness of 0.059 ± 0.031 mm.
3.2 In situ oxidative polymerization of Py
After membranes production, in order to turn them into electro-stimuli responsive mem-
branes, they were coated with PPy through in situ oxidative polymerization. Polypyrrole
is among various conjugated polymers that are under academic and industrial interest
due to their potential application as bioactuators, biosensors and stimuli-responsive drug
controlled systems [51], [52], [53]. Fibers functionalization with PPy can be performed
through two different methods: by in situ vapor-phase polymerization of Py or by in situ
Py oxidative polymerization. Baptista et al [23], [27] studied the functionalization of
cellulose acetate fibers with PPy using both methods. The first important conclusion
withdrawn from the study was that in situ vapor-phase polymerization resulted in brittle
composite fibers. Therefore, and given the good results obtained by the oxidative poly-
merization, a more detailed study on this method was performed and they came up with
the most adequate conditions to obtain PPy-coated CA fibers. In Table 3.2, these optimal
conditions are listed.
Table 3.2: List of most adequate conditions for in situ oxidative polymerization of Py [27].
Py concentration [M] Oxidant/Monomer ratio Reaction Time [min]
0.05 2 30
Additionally to what has been explained in the Materials and Methods Chapter in
section 2.2, an adjustment to the conditions listed in Table 3.2 had to be done. The
30-minute reaction time proven to be short to fully polymerize the fibers used in the
current work. Instead, a 45-minute reaction under constant stirring was applied, inducing
significant visual changes in the resultant membranes. This difference is depicted in
Figure 3.3 below.
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Figure 3.3: Differences between a 30-minute (left) and a 45-minute (right) polymerization
membrane. The 45-minute polymerized membranes shown a most uniform PPy coating
when compared to the 30-minute one.
Figure 3.4 comprises both types of membranes, the ones obtained by conventional
electrospinning and the others by the coaxial technique, where the pink color is clearly
visible in the case of the conventional setup (a similar result was obtained in [31]). It
also compares and highlights the difference between membranes before and after the
polymerization phase.
Figure 3.4: Comparison between membranes before and after functionalization with
PPy. Pink-coloured conventional membrane highlights the homegeneous distribution
of RhB along the fiber matrix. Coaxial membranes, on the other hand, present a more
heterogeneous distribution, with the RhB suspected to be highly concentrated on the
fibers core.
Since the polymerization method used involves the immersion of the membrane in an
aqueous solution, it was important to estimate the amount of the model drug that would
leave the CA mat by diffusion during this time. Detailed information on this topic will
be presented in the following section of this chapter.
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To analyze and understand the morphological changes subsequent to the polymer-
ization phase, SEM images were obtained for a coaxial polymerized membrane, serving
this example as a representative approach to all the membranes that were functionalized
throughout the work.
Figure 3.5: SEM images and corresponding histogram for fiber diameter analysis of a
coaxial functionalized membrane. A corresponds to a magnification of x5000 and B to a
magnification of x30000.
In terms of membrane polymerization, in the higher magnification image (Figure
3.5B), it is visible that the polymer is uniformly distributed along the different fibers,
showing some agglomerates at a larger scale. Agglomerates presence must be due to an
incomplete washing of the membranes after the polymerization process, being perhaps
more strongly adhered to the nanofibers than the other ones.
While, by SEM, a more detailed analysis on morphological changes can be performed,
electrical conductivity of the functionalized membranes was measured after the polymer-
ization process to evaluate if they were suitable for electrically stimulated drug release
systems.
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As stated in the previous chapter, electrical conductivity values were measured in both
configurations (transverse and planar) and were obtained through the corresponding I-
V curves, being applied a potential difference between -1V and +1V and measured the
resultant current values. An example of this type of curve is depicted in Figure 3.6. To
minimize errors, each measurement was repeated three times.
Figure 3.6: I-V sample curve, obtained from a planar measurement in a conventional
electrospun membrane.
The conductivity values of the electrospun membranes were determined using equa-
tion 2.2. Table 3.3 summarizes the results obtained for the membranes before and after
PPy functionalization. The results shown for the case of a membrane before being covered
with the conductive polymer (uncoated membrane), were withdrawn from the studies
presented in [23].
Table 3.3: Table summarizing conductivities before and after functionalization with PPy.
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In the planar setup, conductivities are measured between two electrical contacts that
are placed in the same plane (membrane´s surface), whereas transverse setup implies
that conductivity is measured across the transversal plane (thickness direction) of the
membrane. During Py polymerization, the fibers at the surface of membrane are uni-
formly coated with PPy which contributes to the higher conductivity (∼10-2 S/cm) using
the planar configuration – as verified in Table 3.3. In transverse configuration, fewer
contact points between fibers coated with PPy or an incomplete Py polymerization of the
inner fibers of the membranes can explain such difference on conductivity values (∼10-5
S/cm).
3.3 Controlled drug release tests
To estimate the amount of Rhodamine B released during the drug release studies, a
calibration curve was performed using solutions of RhB in water with specific known
concentration - listed in the Materials chapter. The absorbance obtained for each solution
in the UV-visible range is depicted in figure 3.7. As already mentioned, RhB is well known
to display absorbance peaks at 190 nm and 554 nm [32], [35], [54]. The calibration curve
obtained at 554 nm is presented in figure 3.8.
Figure 3.7: Absorbances profiles obtained for the known concentrations of RhB aque-
ous solutions. It is clear that 554 nm is the wavelenght for which RhB presents higher
absorbance values.
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Figure 3.8: Calibration curve, calculated for the absorbances registered in the maximum
wavelength peak (554 nm).
As previously explained, before being subject to the controlled drug release tests by
application of an electrical stimulus, membranes must first be functionalized with a
conductive polymer, to turn them into stimuli-responsive substrates. During the poly-
merization step, 2 x 3 cm membrane pieces are immersed in an aqueous solution during
a certain time interval. During this period, Rhodamine B might be disseminated through
the aqueous medium by passive delivery, namely via diffusion. To understand and control
how much of the model drug is lost during this period, it is important to simulate such
process through a controlled diffusion release study. This study is performed simply by
immersing a membrane in a certain volume of water and measuring the corresponding
absorbances in specific time instants. Using then the calibration curve depicted in Figure
3.8, the absorbances are converted into concentration units. To obtain the desired drug
release profiles, the estimated amount of RhB encapsulated in nanofibers is also an es-
sential parameter to be measured. By dissolving an uncoated membrane in 1 mL acetone
solution, due to the high solubility of CA in such solvent, dissolution of the membrane
occurs and, after acetone evaporation, only RhB remains. Filling the recipient with a cer-
tain volume of water and measuring the resultant absorbance, the amount of Rhodamine
B previously encapsulated can be estimated.
Therefore, the percentage of Rhodamine B released is obtained by the following equa-
tion:
% of RhB released =
mM of RhB measured
mM of RhB encapsulated
× 100 (3.1)
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Figures 3.9 and 3.10 present a representative example of the results obtained for the
controlled release of RhB by normal diffusion for the conventional and coaxial mem-
branes.
Figure 3.9: Cumulative release profile via diffusion for the case of a conventional uncoated
membrane. Absorbances were measured after 1min, 5min, 10min, 20min, 30min, 50min,
60min, 4h, 24h and 48h membrane had been immersed.
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Figure 3.10: Cumulative release profile via diffusion for the case of a coaxial uncoated
membrane. Absorbances were measured after 1min, 5min, 10min, 20min, 30min, 50min,
60min, 4h, 24h and 48h membrane had been immersed.
As it can be stated by comparing both figures, percentage of RhB released reaches
higher values for the case of the membrane produced by conventional electrospinning.
This difference was expected due to the inhomogeneous drug distribution in the overall
fiber that characterizes fibers obtained via the coaxial setup. It means that, in the case of
the coaxial membranes, RhB is probably more concentrated in the fibers interior, driven
from the way fibers are produced, whereas for the case of the conventional electrospun
membranes, drug presents an higher surface distribution. Despite the mentioned differ-
ences, one common conclusion that can be withdrawn from analysis of both profiles is the
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overall low percentages of the model drug that get released during the time interval con-
sidered. Looking carefully to the total amount of time consumed by the polymerization
step (approximately 55 minutes), during which membrane is immersed in an aqueous
solution, for both types of membranes, the percentage is considerably small. This means
that, after being polymerized, the majority of the model drug is still encapsulated, en-
abling further studies on controlled release by application of an external stimulus.
Since the final goal of this thesis is to electrically stimulate the obtained membranes
and then analyze its responsive behavior, the expectation is to obtain a certain drug
release profile, ideally with the drug diffusing out of the membrane earlier than what was
verified for the diffusion study mentioned above. However, before starting the stimulated
controlled release study, a similar logic as the one explained above is needed. Thereby, if
a study of the percentage of RhB released during the functionalization of the membranes
was necessary, so it is in the case of understanding how the functionalized membranes will
behave when immersed in water during the electrically controlled studies. Studying the
diffusion of the model drug in this case is crucial to clarify, after applying the stimulus
and measuring the absorbances, how much of the RhB is released via diffusion or by
application of the electrical stimulus.
The following figures present the drug release profiles, only by diffusion, of both
types of membranes coated with conductive polymer.
Figure 3.11: Cumulative release profile via diffusion for the case of a conventional coated
membrane. Absorbances were measured after 1min, 5min, 10min, 20min, 30min, 50min,
60min, 4h, 24h and 48h membrane had been immersed.
It is important to underline, given the results of the above figures, that despite the
measured absorbances had been higher for the conventional electrospun membranes,
since the concentration of the model drug encapsulated in these fibers is also higher (7
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Figure 3.12: Cumulative release profile via diffusion for the case of a coaxial coated
membrane. Absorbances were measured after 1min, 5min, 10min, 20min, 30min, 50min,
60min, 4h, 24h and 48h membrane had been immersed.
x 10-3 mM) than the one registered for the coaxial case (3 x 10-3 mM), when converting
it up to percentage, the ratio difference in the equation 3.1 will be much lower for the
case of the coaxial membranes, leading to high percentage values. Furthermore, the PPy
coating induces significant differences in terms of release profiles. The model drug takes
much longer, specially in the conventional electrospun membranes, to diffuse out of the
nanofibers and percentages registered are much lower than the ones measured in the
uncoated case.
As it can be easily highlighted in the absorbances profiles depicted in Figure 3.7,
RhB presents two distinguishable absorbance peaks. Typically, research works that rely
on RhB to model a drug in their controlled release studies [31], [32], [54], focus their
attention on the absorbances registered for the wavelength of 554 nm, as it is considered
the maximal absorbance peak of this substance – as indicated in the Materials Chapter.
This also justifies why the calibration curve (Figure 3.8) was calculated for the absorbances
measured at the wavelength of 554 nm.
Without any literature support, once again an exploratory study was employed in
order to understand what type of results would be obtained depending on the different
conditions applied. Table 3.4 lists the different case studies that were outlined and per-
formed. In every case listed, the process was identical, despite the differences between
parameters of each case: membrane was partially immersed in a 20 mL volume of water,
application of the stimulus was done immediately and, after the corresponding appli-
cation time, membrane was removed and 3 mL of the solution were measured in the
UV-spectrometer.
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Table 3.4: List of conditions attempted in electrically controlled drug release studies.
Figure 3.13 depicts a representative example of the type of result that was obtained
to every case attempted and listed in Table 3.4.
Figure 3.13: Example of curve obtained for case nr. 2 listed in Table 3.4.
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From the analysis of the above figure, it can be stated that no reaction, in terms
of absorbance variance, was denoted in the region of interest (around 554 nm). Only
around the 190 – 200 nm region was that variance registered. However, with a closer
look over this area and performing a more quantitative analysis, it is verified that there is
no relationship between these values and the change of conditions being applied to the
system. Therefore, drug release was not verified for any of the cases mentioned above.
Given the difficulties in obtaining the desired results, a review of the literature was
made with the aim of identifying a list of possibilities that could be limiting the diffusion
of RhB out of the membrane through application of a stimulus.
Research studies were found on the degradation of RhB, either by temperature or due
to UV exposure; it was also considered the hypothesis of, despite the low percentage of
the model drug lost during polymerization, the amount left could not be concentrated
enough to produce any impact on the absorbance measurement; the ultimate reason
pondered to be causing such difficulties was the short period of time that separated the
stimulus being applied from the UV-abs measurement.
In order to study the influence of the UV radiation on the samples used in this work,
a 2 x 3 cm piece of membrane, produced by the conventional electrospinning technique,
was exposed to an UV-light (380 nm) for 3 consecutive hours. After this time, the mem-
brane was immersed in a 20 mL water volume and its diffusion profile was studied and
matched with the one previously obtained for the same type of membrane, as represented
in figure 3.9.
Figure 3.14: Diffusion drug release profiles comparison - UV vs Normal.
From Figure 3.14, it is assumed that UV influence on the membranes used throughout
this work can be neglected, due to similarity between values of both profiles. Despite not
being in direct contact with any temperature source, any excessive stirring of solutions
or any proximity from a temperature source itself in a lab environment could lead to a
raise in temperature values at the membranes surface. Thereby, an identical study as
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the one discussed above to the UV radiation was performed, for the case of the tempera-
ture. According to González and Frey [31], in their research work, they have cured their
electrospun membranes containing RhB at a temperature of 180ºC to avoid model drug
degradation. The main differences were verified visually, with the reduction of the pink
intensive colour, since in terms of drug release, the corresponding profile did not change
abruptly, when compared to the normal diffusion one (Figure 3.15).
Figure 3.15: Visual difference before (A) and after (B) membrane curing.
Figure 3.16: Diffusion drug release profiles comparison - Normal vs Cured.
With the aim of identifying if the amount of RhB encapsulated in the membrane
was concentrated enough to produce any impact on the absorbance measurement, the
membranes that were previously subject to the various stimulus applied in the different
case scenarios listed in Table 3.4, were left immersed for a few days and the corresponding
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UV-abs values were measured after this period. Figure 3.17 represents an example of the
UV-vis absorbance profile of a conventional membrane, previously stimulated with a
positive polarity signal, left immersed for 3 days.
Figure 3.17: UV-vis absorbance profile of a previously stimulated conventional membrane
left immersed for 3 days.
It is clearly detectable the short but distinguishable peak in the region of interest,
which automatically set aside the hypothesis that was being tested. It turns out that the
amount of RhB encapsulated is still enough to be detected by the equipment. This was
the onset that led to the final hypothesis thought to be avoiding the release of the model
drug under application of an electrical stimulus.
Overviewing the results already discussed: temperature and UV radiation were clari-
fied to not having a relevant impact on the RhB release; it was proven that, by applying
stimulus on a membrane and left her immersed for a few days, produced better results
than the ones obtained in the moment of performing the tests. That being the case, the
procedure adopted to perform the electrically controlled release was modified: instead
of applying the stimulus and measuring the absorbance of the medium right after the
stimuli application time, it was studied the hypothesis of applying a stimulus and measur-
ing the corresponding absorbances only after a while, specifically 30 minutes. The new
method was performed first on membranes produced by conventional electrospinning.
In order to compare the resultant profile with the corresponding diffusion one presented
in Figure 3.11, a +5V stimuli was applied and then the first absorbance measure was per-
formed only after half an hour, being the last one taken 48h after the stimuli application.
Results were repeated for the negative polarity of the signal and then faced against the
normal diffusion profile and are represented in Figure 3.18.
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Figure 3.18: Electrically controlled release profiles after 1 single stimulus against normal
diffusion release comparison – conventional electrospun membranes.
Interestingly, and despite the low percentages measured during the considered pe-
riod of time, it is possible to distinguish different behaviors between profiles. It can be
stated that, until a certain time, namely 1h30 after stimuli application, any of the profiles
presented signals of RhB release. This common scenario is disrupted hours later (4h),
moment at which membrane stimulated with the positive polarity signal loses some of
the model drug from its nanofibers mat, considerably sooner that the other assessed situa-
tions. After 24h, every membrane has already registered a certain absorbance value, being
important to highlight that the positive polarity stimuli still present the major response,
followed by the membrane subject to normal diffusion and lastly by the other stimulated
membrane. Such tendency is reinforced at the measurement performed after 48h, where
differences between both stimulated situations is abruptly higher than the previous in-
stant. There are a few conclusions to be withdrawn from this novel approach study: the
first being the statement that there is a difference between measuring absorbances right
after stimuli application versus this later situation, where membrane is left immersed
during a certain period, so that the drug can have time to disassociate from the encapsu-
lating fibers and disseminate to the surrounding medium. Another important conclusion
is the difference between polarities of the stimuli. Clearly the positive stimuli induced a
much stronger response on the membrane comparing to the opposite polarity. This result
was theoretically expected: since the PPy layer is being charged with a positive external
stimulus and given the positively charged aminoxanthene group of RhB backbone chain
[55], they would repel each other, easing RhB release to the medium. Oppositely, if a
negative electronic charge is induced to the conductive polymer, the tendency would be
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for the PPy to stronger retain RhB inside the fibers, given their electronic attraction.
Once verified that the positive stimulus was the one to which membranes were more
sensitive, impact of the amount of voltage induced was studied. Since the macro objective
of developing this kind of systems is to incorporate them into biodevices, as an example,
smart wound dressings, voltages over 5V would not be advisable, given the inherent risk
it brings to the human wellbeing. Therefore, values below this one were tested, namely
+1V and +3V. Additionally to the study of the impact of varying voltage value, this last
study was also outlined with the aim of reaching, if possible, the characteristic profile of
an on-off switch release system. This switch-like profile would enable an higher control
over the drug release, not only in terms of amount released, but also in which instants the
release would occur. Ideally, according to the mentioned profile, the membrane would
only release the drug in the instants after the stimulus have been applied and would
remain approximately constant until the following stimulus application.
That being said, the figure that follows contains a series of dashed lines with the word
“ON” at the top. This corresponds to the moment the stimulus was applied. As it was
done in the prior study, absorbances were only measured at least after 30 minutes from
the moment the stimulus stopped being applied and the duration of the stimulus was also
5 minutes. There was, however, some periods during which the membrane was simply
immersed, with no external stimuli application. Absorbances were measured during
these periods so that the mentioned on-off desired property could be assessed.
Figure 3.19: Release profiles for different voltage values and "on-off"property study for a
conventional electrospinned membrane.
Analyzing Figure 3.19 and comparing it to the previous release profile shown above,
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it is important to highlight several common and different aspects between both: as pre-
sented in Figure 3.18, in Figure 3.19, despite the extra stimulus applied after half an
hour, the percentage of released RhB was still null after one hour of the membranes being
immersed. Differences started to be noticed 30 minutes later, where a third applied stim-
ulus led to an earlier RhB release when compared to the scenario studied before. This
difference is justified by the application of two additional stimulus in this latter case,
leading to the same amount of model drug released for all three voltage values. From this
instant of time until the three hours of membrane immersion, no stimulus was applied to
the membranes and absorbances continued to be measured in 30-minute intervals. Inter-
estingly, every stimulus applied led to the same result in terms of drug release. The aim of
the study during this period was to understand whether the membrane could be consid-
ered sensible to a switch on-off profile. Thereby, by maintaining its value of RhB release
throughout this period, it meant that no drug was being released without the stimulus
application. The exception occurred at the last instant measured (3h), where a subtle rise
of the released percentage was registered, probably inherent to some natural diffusion by
the amount of time it had been immersed. A new stimulus was applied right after 3h had
passed, which it was expected to raise the percentage of drug release, therefore confirm-
ing a switch-like profile. However, after 30 minutes, this increase only occurred for the
higher voltage applied. The following half an hour had no stimulus application, where it
was verified, at the end of this period, that +5V was fitting perfectly in the desired on-off
profile; +3V appeared to have a late response to the stimulus applied 1h before and +1V
revealed to be less sensitive to the switching stimulus application. A final stimulus was
induced after 4h of membrane immersion, where differences between voltage values were
emphasized and additional conclusions in terms of release profiles could be withdrawn.
At the 4h30 instant, the membrane subject to the +5V voltage confirmed its sensitivity
to a switchable on-off profile; followed by the +3V membrane which, despite the slow
response to the stimulus, also presented to be sensitive to an on-off system; and the lowest
voltage value induced, though the membrane had proven to be sensitive to the stimulus
application, with its extremely slow response, it is a system that cannot be characterized
by having the capacity to an on-off switchable profile. Later periods assessed, namely 24h
and 48h after membrane had been immersed, were useful only to prove that membranes
are clearly more sensitive to a higher electrical stimulus, with a significant difference in
terms of drug release percentages after two days of immersion.
For the coaxially produced membranes, electrically controlled release studies were
extended only until the comparison between the polarity of the stimulus and the normal
diffusion release profiles for this type of membranes (equivalent to the results presented
in Figure 3.18 in the discussion above). The conditions under which the study was
performed were identical to the conventional membranes study, where the stimuli were
applied during 5 min and absorbances were measured along the same time intervals,
being then converted to release percentages.
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Figure 3.20: Electrically controlled release profiles against normal diffusion release com-
parison – coaxial electrospun membranes.
Comparing to the conventionally electrospun membranes, differences between volt-
age values do not induce such significant impact on the membranes release capacity when
faced against the profile obtained for the normal diffusion of these membranes in an aque-
ous solution. However, after 48h of the membrane being immersed, it is visible the higher
sensivity of the membrane to the positive polaritity. Once again, the reason behind this
behavior is related with the electromigration of RhB towards the electrode, facilitated by
electronic repulsion between equal charged molecules of PPy and the model drug.
Beyond the drug release capacity of both types of membranes produced, a further
study was performed to understand the impact that electrically controlled applied stimuli
can have on the morphology of the given membranes and also if it changes considerably
the conductivities previously measured.
SEM images were acquired for the membranes produced by coaxial electrospinning
and subject to a 5V stimulus, one with the positive polarity and the other one with the
negative.
46
3.3. CONTROLLED DRUG RELEASE TESTS
Figure 3.21: SEM images and corresponding histogram for fiber diameter analysis of a
coaxial functionalized membrane subject to an external positive stimulus. A corresponds
to a magnification of x5000 and B to a magnification of x30000.
The major difference relatively to the membranes case discussed prior to the controlled
release tests is the softness of the surface. Whereas on the absence of stimulus, the
surface of the analyzed samples looks smoother, after being subjected to the stimulus
it gets visually rougher. This change in the surface roughness might be explained by
the immersion of a piece of the membrane in the water, so to initiate the tests, period
during which some poorly adhered PPy particles may start to disaggregate from the
nanofibers. Another possible reason for this morphological change may be due to some
conformational changes that might occur when PPy is charged with either positive or
negative charges, related to the change of the overall net charge of the polymer [52]. The
step of immersing a part of the membrane in the water also explains the reason why
nanofibers subjected to the stimulus present larger diameters than those that had just
been polymerized (Figures 3.21C and 3.22C). This is due to the swelling behavior that
nanofibers are subject to as soon as they start to absorb water, inherently increasing their
diameter size [9].
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Figure 3.22: SEM images and corresponding histogram for fiber diameter analysis of a
coaxial functionalized membrane subject to an external negative stimulus. A corresponds
to a magnification of x5000 and B to a magnification of x30000.
Conductivity measurements were performed for the membranes produced by both
methods and subject to the studies mentioned above. Comparison between the number
of stimuli applied to the membrane is presented and the value chosen was the +5V since
it registered the best results during the study. Parameters listed in the Materials and
Methods chapter were defined, conductivities were measured and then compared to the
values obtained for the coated membranes before controlled release tests (corresponding
to the case of 0 number of stimuli applied). Results are summarized in Table 3.5 and
discussed below.
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Table 3.5: Summary of the conductivities obtained under several conditions studied
throughout the work.
From the values summarized in the above table, a common conclusion to every situa-
tion is the fact that the conductivities measured after stimuli application are lower than
the ones measured prior to the controlled release studies. This is mainly due to the time
during which PPy was immersed in the water, leading to a change of its protonation state
and in turn to a different oxidation state as well. Another possible cause to the decrease
of conductivity values was the loss of part of the coating during the time membrane was
immersed in the water, especially the aggregates of PPy that were less adhered to the
nanofibers surface.
For the study where only one stimuli was applied in order to understand to which
polarity was the membrane more sensitive, an interesting statement can be made: the
conductivities measured in the case of the membrane stimulated with the +5V voltage,
which proved to be the polarity to which membranes were more sensitive, registered lower
values than the ones obtained for the -5V voltage. It may be justified by the repulsive
force that the conductive polymer felt against the oppositely charged RhB, easing some
PPy molecules to disaggregate from the surface, which otherwise would not happen if
those molecules were attracted to the model drug (it happens in the case of the negative
polarity). Repeating the stimulus application for several times would only contribute to
this repulsive phenomenon, thereby leading to the even lower conductivities registered
in the last case of several stimuli applied.
49

C
h
a
p
t
e
r
4
Conclusions and future perspectives
In the work hereby presented, the aim was to combine an innovative set of drug-carrier
materials, explore both conventional and coaxial electrospinning techniques in order to
obtain a uniform nanofiber membrane, coating it with a conductive polymer and studying
its behavior as a controlled drug release system.
The membranes production step demanded an extensive and detailed study, espe-
cially in the coaxial setup, so that an optimal combination between the carrier and the
drug solutions could be found. For this particular setup, an 8% wt. Cellulose Acetate
solution was used to form the shell layer, as a 0.6 mM Rhodamine B solution was injected
into the core of the nanofibers. Additionally, conventional electrospinning technique
was also studied, with the aim of developing a continuous comparison work between
membranes obtained via both types of techniques throughout every part of the work. In
the conventional setup, an identical amount of RhB (used in the 0.6 mM solution) was
added to an 8% wt. solution of CA in order to obtain a unique solution containing both
drug and carrier.
Optical Microscopy and SEM were used to characterize the fibers morphology and,
mostly by OM, to analyze if the fibers contained RhB in its interior. The main conclusions
to be withdrawn from the OM analysis are that conventional electrospun membranes
showed a more homogeneous drug distribution over the fibers matrix, compared to the
coaxially obtained membranes, where the drug is supposed to be highly concentrated in
the nanofibers core. From the SEM analysis, using the coaxial setup to encapsulate RhB,
the electrospun fibers showed a higher average diameter and a rough surface. The larger
diameters are due to the larger gauge of the outer needle used for coaxial setup when
compared with the conventional one. The surface roughness can probably be explained
by the interaction of cellulose acetate molecules in the shell with the water molecules
embedded in the core (containing RhB).
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In terms of membranes functionalization, the conditions previously optimized by
Baptista et al. [27] in their study were replicated and adjusted to the work here devel-
oped. The 30-minute reaction time stated in the mentioned study proven to be short
to fully polymerize the fibers used in the current work. Instead, a 45-minute reaction
under constant stirring was applied, inducing a complete functionalization of the whole
membranes.
Electrical conductivity values were measured in both configurations (transverse and
planar) and were obtained through the corresponding I-V curves. In the planar setup,
conductivities are measured between two electrical contacts that are placed in the same
plane (membrane´s surface), whereas transverse setup implies that conductivity is mea-
sured across the transverse plane (thickness direction) of the membrane. During Py
polymerization, the fibers at the surface of membrane are uniformly coated with PPy
which contributes to the higher conductivity (∼10-2 S/cm) obtained using the planar con-
figuration. In transverse configuration, fewer contact points between fibers coated with
PPy or an incomplete Py polymerization of the inner fibers of the membranes can explain
the difference observed on conductivity values (∼10-5 S/cm).
After the performance of different studies to analyse the amount of RhB that was loss
by passive diffusion (only by immersing the membrane in water), the membranes were
exposed to different signal polarities stimuli in order to find out to which polarity were
the membranes more sensible, in terms of drug release. As it can be stated by the results
presented in the Results and Discussion chapter, the positive stimuli induced a stronger
response on the membrane compared to the opposite polarity. Following this conclusion,
further studies were carried out to understand the influence that stimuli voltage values
could have on the drug release, being at the same time explored the sensibility of the
membranes studied to a on-off switchable pattern. The results obtained shown that the
higher the voltage value, the better the membrane could follow the desired on-off profile,
also releasing higher amounts of RhB. Thereby, by successfully adjusting the system into
a switchable-like profile, a better control over the drug release pattern can be obtained.
The main goal of developing this kind of systems is to further integrate them into
bioactuators devices, such as a smart wound dressing as an example. Therefore, to achieve
something so sensible and efficient as a system like that would require, a lot of work is still
to be done. This work, along with several others already developed, aims to contribute to
the diversification of functionalities this type of systems can have. Here, it was presented
a novel approach to an innovative drug-carrier system, where the capacity of switching
the drug release in an on-off pattern-like was tested out. Moreover, the option for organic
and biocompatible polymers was made, following a sustainable policy. The choice of a
model drug instead of a real one, which for the matter of the studies here performed was
justified, also helped and contributed to a reduced overall economic investment, along
with the techniques and other materials used.
Despite the difficulties encountered throughout the work, a new idea of future study
or application ended up being discovered. Oppositely to the majority of drug delivery
52
systems, the PPy association to the CA-RhB system clearly hindered the spontaneous
release of the model drug from the nanofibers mat, which is typically one of the most
common issues associated with these systems. However, the most negative aspect about
the results obtained in this work was, in fact, the low percentages of the model drug
released. In a future research work working with this same combination, it would be
important to study the relationship between RhB and PPy, to better understand how they
interact and if that could be a possible cause to the low percentages registered. Having
this situation solved, it would certainly need further testing, but it would be an interesting
system to be tried out with a real drug and to ponder its integration on a real sensory
device.
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